IDEA RESEARCH. Q2FY19 Result Update Tuesday, November 13, Mold Tek Packaging Lower gross margins & higher interest cost impacts profitability

Similar documents
Maruti Suzuki. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Bharat Petroleum Corporation

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Britannia Industries

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Cig volumes surprise. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Jindal Steel & Power

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Gujarat State Fertilisers & Chemicals

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Aurobindo Pharma. Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Glenmark Pharmaceuticals

HDFC Standard Life Insurance

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

Bayer Cropscience (BYRCS IN)

Jindal Steel & Power

GMR Infrastructure. Airport revenues on a thaw, Power awaiting its turn. Q3FY13 Result Update

Tata Steel. Source: Company Data; PL Research

ICICI Prudential Life Insurance

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Indraprastha Gas. Source: Company Data; PL Research

Apollo Tyres. Profitability likely to improve. Source: Company Data; PL Research

Source: Company Data; PL Research

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

FY20E FY21E FY20E FY21E

Larsen & Toubro (LT IN)

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Dabur India. Source: Company Data; PL Research

Britannia Industries

LIC Housing Finance. Source: Company Data; PL Research

Pantaloon Retail India

Aurobindo Pharma. Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Dr. Reddy's Laboratories

Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Glenmark Pharmaceuticals

Cadila Healthcare. Source: Company Data; PL Research

Bharat Electronics (BHE IN)

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Punjab National Bank

Dr. Reddy's Laboratories

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Mindtree. Source: Company Data; PL Research.

Maruti Suzuki (MSIL IN)

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Transcription:

(MTEP) reported Q2 results, slightly below expectations. Cons. net sales grew by 27.1% YoY but were marginally lower sequentially to Rs 1,005m. Q2 is a seasonally weak quarter (Q1 and Q4 being stronger). EBITDA grew 19.1% YoY to Rs 166m but was down QoQ by 6.9% to Rs 166m primarily due to 240 bps contraction in gross margins as well as increase in employee costs by 23% YoY. EBITDAM were down 110 bps YoY and 90 bps QoQ to 16.5%. Adj. PAT stood at Rs 73m versus Rs 82m in Q1FY19 and Rs 71m in Q2FY18. For the half year, net sales/ebitda/pat grew by 20.0%/15.7%/8.9% to Rs 2,028m/Rs 344m/Rs 155m. EBITDAM contracted by 60 bps to 17.0% in spite of gross margin contraction of 230 bps, due to benefits from operating leverage. Depreciation increased by 20.9% to Rs 75m due to increase in WIP from Rs 147m to Rs 337m (capex at Mysuru and Vizag) and interest cost by 73.6% to Rs 34m as long term debt increased 2.5x to Rs 50m. Post results, we have revised our consolidated topline estimate for FY19E upwards by 3.0% to Rs 4,212m but lowered the profit estimates by 6.4% to Rs 349m due to lower per kg EBITDA (Rs 33.3 vs Rs 33.8 previously) and higher interest cost (Rs 68m vs Rs 52m) cost. For FY20E, the topline estimate unchanged but the profit estimate has been revised downwards by 2.4% to Rs 481m in spite of improvement in per kg EBITDA (Rs 34.5 vs Rs 34.3) due to lower volume growth (19.6% vs 22.3%) and higher interest cost. While the company continues to face headwinds at the RAK plant, they have already taken steps to course correct and in accordance are moving surplus unutilized capacity to India, which coupled with the two new plants at Vizag and Mysuru, good traction in edible oil and ice cream segments and continued addition of new marquee clients across segments provide good visibility for 20% volume growth in FY20E. Although optimal benefits of operating leverage are not visible currently, we expect it to improve once the two new plants are stabilized. At CMP, the stock is trading at PER of 20.9x FY19E and 15.2x FY20E revised EPS estimates of Rs 12.6 and Rs 17.4 respectively. We maintain our BUY rating on the stock with a TP of Rs 365 (21x FY20E EPS). Lower gross margins & higher interest cost impacts profitability Q2FY19 Result Update Tuesday, November 13, 2018 Shailee Parekh shaileeparekh@plindia.com +91-22-66322302 Charmi Mehta charmimehta@plindia.com +91-22-66322274 Rating BUY Price Rs 264 Target Price Rs 365 Implied Upside 39% Sensex 34,813 Nifty 10,482 Bloomberg Code Reuters Code (Prices as on November 12, 2018) Tracking Data MTEP.IN MOLT.BO Market Cap (Rs bn) 7.3 Shares O/s (m) 27.7 3M Avg. Daily Value (Rs m) 19.0 Key financials (Y/e March) 2017 2018 2019E 2020E Revenues (Rs m) 3,014 3,468 4,212 5,142 Growth (%) 9.3 15.1 21.4 22.1 EBITDA (Rs m) 504 615 727 953 PAT (Rs m) 242 278 349 481 EPS (Rs) 8.8 10.0 12.6 17.4 Growth (%) 8.1 15.1 25.4 37.9 CEPS (Rs) 8.7 14.8 18.1 23.9 Net DPS (Rs) 3.2 2.0 2.0 2.0 Profitability & Valuation 2017 2018 2019E 2020E EBITDA margin (%) 16.7 17.7 17.3 18.5 RoE (%) 15.1 16.2 17.6 20.6 RoCE (%) 14.8 16.7 18.8 21.4 EV / sales (x) 2.6 2.4 1.9 1.6 EV / EBITDA (x) 15.5 13.4 10.9 8.5 PE (x) 30.0 26.2 20.9 15.2 P / BV (x) 4.6 4.0 3.4 2.9 Net dividend yield (%) 1.2 0.8 0.8 0.8 Source: Company Data, PL Research Major Shareholders Promoters 35.6 Domestic Inst. 12.5 Public & Others 51.9 Stock Performance (%) 1M 6M 12M Absolute 0.3 (24.9) (17.1) Relative (0.7) (22.9) (19.7) How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2019E 12.6 12.3 2.4 2020E 17.4 16.1 8.1 November 13, 2018 1

Key highlights for the quarter are: Low sequential volume growth as Food segment lags Total volumes grew by 19.5% YoY but marginally down by 1% QoQ to 5,425 tons. Paint volumes at 2,760 tons were flat, lubes at 1,811 tons up 32.0% YoY and food at 697 tons - up 74.3% YoY in spite of slowdown in Mondeles volumes. Management has guided ~15% volume growth in FY19E and 20%+ growth in FY20E on back of ramp up in Vizag and Mysur plants and increased traction in ghee and edible oil segment. Higher cost of imported printing materials and inks dents gross margins Raw material prices dropped from Rs 99/kg to Rs 95/kg for a month and then bounced back. Thereafter it hovered around the same levels and has been more or less flat since then. Prices of imported IML printing material and inks increased due to the rupee depreciation. This led to an impact of Re 1/kg on gross margins. Gross margins were down by 240 bps YoY and 40 bps sequentially to 38.9%. Any increase/correction in prices is typically passed on with a one month lag. ~75% orders has a monthly reset clause and the balance on a quarterly basis. Invoicing started from Mysuru plant in November, commercial production by mid-december Construction activities almost completed at Mysuru plant for Asian Paints and orders have been received and invoicing started from November 10, 2018 however current supplies are being made from the Karnala plant. Commercial production will begin at the Mysuru plant from mid December. 70% of Construction at Vizag plant is also completed and production may start from February, 2019. MTPL is expecting to achieve volumes of 600-800 MTPA in FY19e and ~3000 MTPA (revenues of Rs 400-500m) in FY20E from both plants combined. Both plants are expected to be EBITDA neutral in spite of being based on HTL technology due to superior designing. Weak demand and pricing outlook leads to capacity shifting from RAK to Hyderabad RAK Unit has bagged order from new customers like Novasolum specialty Chemicals LLC, Magnum Lubricants and Gulf Oil Middle East etc and orders from other new clients. However traction from the Paint and Dairy industry continues to remain abysmal. The company is planning to shift 2 more large machines by December this year to India for better overall utilization. This will bring down the RAK capacity from 3,000 MTPA to 1,800 MTPA. We believe the company will end with volumes of ~750 MTPA in FY19E. At a monthly run rate of 100 tons, they will break even and hope to achieve these levels by end of this fiscal. New Client Addition in Ice Cream and Edible oil During the quarter the company has added Hindustan Unilever as a client in the ice cream segment. Although the order is not very large, addition of a marquee client like HUL offers room for scalability in the future. The company is also witnessing very good response in the ghee and edible oil segment and added 7-8 new clients here. Edible oil revenues which were ~ Rs 15m in Q1FY19 has increased to Rs 40m in Q2FY19. November 13, 2018 2

Capex plans MTPL has a capex plan of Rs 450m for FY19E (Rs 300m already spent in H1FY19) to be incurred on capacities at Vizag and Mysuru, setting up a brown field capacity for edible oil at Hyderabad and maintenance capex. ~1,200 tons capacity is being moved to Hyderabad from RAK which will be used for demand from the edible oil segment. Current capex plan for FY20E is Rs 150-180m which will be funded by way of internal accruals. There are also plans for Phase II expansion at both Mysuru and Vizag, which will go on stream by March and June 2020. In case of greenfield expansion in the North, the cost could increase by further Rs 200m in which case the company might have to borrow. Financial Overview and Valuations Post results, we have revised our consolidated topline estimate for FY19E upwards by 3.0% to Rs 4,212m but lowered the profit estimates by 6.4% to Rs 349m due to lower per kg EBITDA (Rs 33.3 vs Rs 33.8 previously) and higher interest cost (Rs 68m vs Rs 52m) cost. For FY20E, the topline estimate unchanged but the profit estimate has been revised downwards by 2.4% to Rs 481m in spite of improvement in per kg EBITDA (Rs 34.5 vs Rs 34.3) due to lower volume growth (19.6% vs 22.3%) and higher interest cost. While the company continues to face headwinds at the RAK plant, they have already taken steps to course correct and in accordance are moving surplus unutilized capacity to India, which coupled with the two new plants at Vizag and Mysuru, good traction in edible oil and ice cream segments and continued addition of new marquee clients across segments provide good visibility for 20% volume growth in FY20E. Although optimal benefits of operating leverage are not visible currently, we expect it to improve once the two new plants are stabilized. At CMP, the stock is trading at PER of 20.9x FY19E and 15.2x FY20E revised EPS estimates of Rs 12.6 and Rs 17.4 respectively. We maintain our BUY rating on the stock with a TP of Rs 365 (21x FY20E EPS). November 13, 2018 3

Q2FY18 Result Overview (Rs m) Y/e March Q2 19 Q2 18 YoY gr. YoY gr. Q1 19 H1 19 H1 18 (%) (%) Net Revenue 1,005 761 27.1 1,023 2,028 1,690 20.0 Expenditure Raw Material Cost 614 464 32.2 621 1,235 990 24.7 % of revenue 61.1 58.7 60.7 60.9 58.6 Employee Cost 109 88 23.1 104 212 175 21.1 % of revenue 10.8 11.2 10.1 10.5 10.4 Other Expense 116 99 18.0 120 237 227 4.3 % of revenue 11.6 12.5 11.8 11.7 13.4 Total Expenditure 839 651 28.8 845 1,684 1,392 20.9 EBITDA 166 139 19.1 178 344 297 15.7 Margin (%) 16.5 17.6 17.4 17.0 17.6 Depr. & Amortization 38 32 18.8 37 75 62 20.9 EBIT 128 107 19.1 141 269 235 14.3 Net Interest 17 9 92.9 16 34 19 73.6 Other Income 5 2 121.1 4 9 6 61.8 Profit before Tax 116 101 14.9 129 244 221 10.4 Total Tax 43 30 44.8 47 90 80 13.0 Effective tax rate (%) 37.2 29.5 36.3 36.8 35.9 Profit after Tax 73 71 2.3 82 155 142 8.9 PAT Margin (%) 7.2 9.0 8.0 7.6 8.4 EPS 2.6 2.6 2.3 3.0 5.6 5.1 8.9 Source: Company Data, Idea Research November 13, 2018 4

Income Statement (Rs m) Net Revenue 3,014 3,468 4,212 5,142 Raw Material Expenses 1,862 2,059 2,559 3,070 Gross Profit 1,151 1,409 1,653 2,072 Employee Cost 286 364 440 530 Other Expenses 361 430 486 590 EBITDA 504 615 727 953 Depr. & Amortization 103 132 153 180 Net Interest 24 46 68 70 Other Income 8 10 15 16 Profit before Tax 385 447 521 718 Total Tax 143 169 172 237 Profit after Tax 242 278 349 481 Ex-Od items / Min. Int. (1) - - - Adj. PAT 243 278 349 481 Avg. Shares O/S (m) 27.7 27.7 27.7 27.7 EPS (Rs.) 8.8 10.0 12.6 17.4 Cash Flow Abstract (Rs m) C/F from Operations (168) (398) 63 (249) C/F from Investing 49 9 (50) (40) C/F from Financing 266 447 86 95 Inc. / Dec. in Cash 147 58 100 (194) Opening Cash 83 333 (44) (37) Closing Cash 10 9 10 408 FCFF (119) (388) 13 (289) Key Financial Metrics Growth Revenue (%) 9.3 15.1 21.4 22.1 EBITDA (%) 15.1 22.1 18.1 31.1 PAT (%) 8.1 15.1 25.4 37.9 EPS (%) 10.0 14.5 25.4 37.9 Profitability EBITDA Margin (%) 16.7 17.7 17.3 18.5 PAT Margin (%) 8.0 8.0 8.3 9.4 RoCE (%) 14.8 16.7 18.8 21.4 RoE (%) 15.1 16.2 17.6 20.6 Balance Sheet Net Debt : Equity 0.3 0.5 0.3 0.3 Net Wrkng Cap. (days) 89.0 106.7 83.0 83.0 Valuation PER (x) 30.0 26.2 20.9 15.2 P / B (x) 4.6 4.0 3.4 2.9 EV / EBITDA (x) 15.5 13.4 10.9 8.5 EV / Sales (x) 2.6 2.4 1.9 1.6 Earnings Quality Eff. Tax Rate 37.2 37.7 33.0 33.0 Other Inc / PBT 0.0 0.0 0.0 0.0 Source: Company Data, PL Research. Balance Sheet Abstract (Rs m) Non-Current Assets 1,367 1,656 1,706 2,043 Net fixed assets 1,081 1,324 1,446 1,716 Capital Work In Progress 97 148 - - Other Intangible Assets 2 3 3 2 Intangibles under development - 1 - - Investment property 1 1 - - Non-Current Investments 112 103 153 193 Other financial assets 2 2 22 42 Other Non-Current Assets 71 74 82 90 Current Assets 1,094 1,482 1,865 2,144 Inventories 367 523 480 586 Trade receivables 615 845 819 1,000 Cash & Bank Balance 9 10 408 347 Loans 1 1 2 2 Other financial assets 18 27 30 34 Current Tax Assets 8 7 12 17 Other Current Assets 75 70 115 160 Total Assets 2,461 3,138 3,571 4,188 Equity Equity Share Capital 139 139 139 139 Other Equity 1,388 1,599 1,886 2,305 Total Networth 1,527 1,738 2,025 2,444 Non-Current Liabilities 211 212 224 236 Long Term borrowings 118 88 88 88 Provisions 19 20 30 40 Deferred tax liabilities 75 104 104 104 Other financial liabilities - - 2 4 Current Liabilities 722 1,188 1,321 1,508 ST Debt / Current of LT Debt 388 863 950 1,045 Trade payables 147 202 199 239 Other current liabilities 99 102 112 123 Short term provisions 70 3 3 3 Other current liabilities 16 15 50 85 Current Tax liabilities 3 3 8 13 Total Equity & Liabilities 2,461 3,138 3,571 4,188 Quarterly Financials (Rs m) Y/e March Q3FY18 Q4FY18 Q1FY19 Q2FY19 Net Revenue 834 924 990 983 EBITDA 156 170 181 171 % of revenue 18.7 18.4 18.3 17.4 Depr. & Amortization 31 32 34 35 Net Interest 10 13 15 16 Other Income 3 1 5 6 Profit before Tax 118 126 137 127 Total Tax 40 49 47 43 Profit after Tax 77 77 90 84 Source: Company Data, PL Research. November 13, 2018 5

DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Ms. Shailee Parekh (MMS, B.com) and Ms Charmi Mehta (CA) authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co-managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Ms. Shailee Parekh (MMS, B.com) and Charmi Mehta (CA), Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai-400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 November 13, 2018 6